Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Veru Inc. - Common Stock (NQ:VERU)

2.448 +0.098 (+4.18%)
Streaming Delayed Price Updated: 10:46 AM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Veru Inc. - Common Stock

News headline image
Veru (VERU) Q1 2026 Earnings Call Transcript ↗
Veru (VERU) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
VERU INC (NASDAQ:VERU) Reports Narrower-Than-Expected Q1 Loss, Highlights Key Clinical Trial Timeline ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
News headline image
A Look Ahead: Veru's Earnings Forecast ↗
 
Via Benzinga
News headline image
Veru's Enobosarm Shows Muscle In Wegovy Combo Trial ↗
Via Benzinga
News headline image
Earnings Scheduled For May 8, 2025 ↗
 
Via Benzinga
News headline image
A Peek at Veru's Future Earnings ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
What's going on in today's after hours session ↗
The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Eli Lilly Ends Bimagrumab Obesity Study Weeks After Launch ↗
On Wednesday, Eli Lilly & Co. (NYSE: LLY) ended a mid-stage study of its experimental drug bimagrumab in obesity patients with type 2 diabetes, just weeks after it began. 
Via Benzinga
News headline image
Earnings Scheduled For February 13, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 12, 2025 ↗
 
Via Benzinga
News headline image
These stocks are gapping in today's session ↗
The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Which stocks are experiencing notable movement on Tuesday? ↗
Curious to know what's happening on the US markets in the middle of the day on Tuesday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps. 
Via Chartmill
News headline image
Which stocks are experiencing notable movement on Monday? ↗
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
News headline image
S&P 500 Falls Over 100 Points; Dada Nexus Shares Spike Higher ↗
 
Via Benzinga
Topics Stocks
News headline image
These stocks are moving in today's session ↗
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
News headline image
Dow Edges Higher; AT&T Posts Upbeat Earnings ↗
 
Via Benzinga
Topics Stocks
News headline image
Traders are paying attention to the gapping stocks in Monday's session. ↗
Let's have a look at the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Veru Shares Tumble Despite Enobosarm's Lean Muscle Preservation Breakthrough ↗
Veru's enobosarm showed significant body composition benefits in Phase 2b trials with semaglutide. Extension study results are due in April 2025. 
Via Benzinga
News headline image
Nasdaq Dips 3%; Chicago Fed National Activity Index Rises In December ↗
 
Via Benzinga
Topics Economy
News headline image
These stocks that are showing activity before the opening bell on Monday. ↗
As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill
News headline image
Veru Sells FC2 Condom Business For $18 Million, Focuses On Biopharma Pipeline ↗
Veru jumps after selling FC2 Female Condom business for $18 million, reducing workforce by 90%. 
Via Benzinga
News headline image
12 Consumer Staples Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Consumer Staples Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
VERU Stock Earnings: Veru Beats EPS, Misses Revenue for Q1 2024 ↗
VERU stock results show that Veru beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.